CaixaBank, S.A.’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
CaixaBank, S.A.'s NBIX Position: Q3 2026 in Review
CaixaBank, S.A. held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 4,704 shares worth $667K. The position accounts for ﹤0.01% of the portfolio, ranked #351.
CaixaBank, S.A. first reported a position in NBIX in Q2 2020 and has held it in 15 quarters since. The position peaked at $4.32M in Q1 2024. 767 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- CaixaBank, S.A. held 4,704 shares of Neurocrine Biosciences worth $667K as of Q3 2026.
- CaixaBank, S.A. left its Neurocrine Biosciences share count unchanged in Q3 2026.
- Neurocrine Biosciences made up ﹤0.01% of CaixaBank, S.A.'s portfolio in Q3 2026, its #351 holding.
- CaixaBank, S.A. first reported a position in Neurocrine Biosciences in Q2 2020 and has held it in 15 quarters since.
- CaixaBank, S.A.'s Neurocrine Biosciences position peaked at $4.32M in Q1 2024.
- 767 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.